{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:10:36Z","timestamp":1793211036863,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ygyno.2016.04.030","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T13:47:04Z","timestamp":1462715224000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain"],"prefix":"10.1016","volume":"142","clinical-trial-number":[{"clinical-trial-number":"nct01898130","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02185352","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Laura M.","family":"Divine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora T.","family":"Kizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith E.","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet S.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-6959","authenticated-orcid":false,"given":"Premal H.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0090-8258(84)90063-5","article-title":"Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients","volume":"17","author":"Aalders","year":"1984","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ygyno.2004.02.006","article-title":"Brain metastases from endometrial carcinoma: a retrospective study","volume":"93","author":"Gien","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/gyno.1996.0093","article-title":"Brain metastases from endometrial carcinoma","volume":"61","author":"Cormio","year":"1996","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2016.04.030_bb0020","first-page":"746","article-title":"Central nervous system metastases in epithelial ovarian carcinoma","volume":"68","author":"Larson","year":"1986","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/B:NEON.0000014516.04943.38","article-title":"Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome","volume":"66","author":"Cohen","year":"2004","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10143-004-0363-4","article-title":"Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases","volume":"28","author":"D'Andrea","year":"2005","journal-title":"Neurosurg. Rev."},{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/gyno.1993.1082","article-title":"Cerebral metastases secondary to ovarian cancer: still an unusual event","volume":"49","author":"Bruzzone","year":"1993","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2016.04.030_bb0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF00607277","article-title":"Calcified brain metastases from ovarian carcinoma","volume":"38","author":"Ricke","year":"1996","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0090-8258(89)90515-5","article-title":"Cerebral metastases in patients with ovarian cancer treated with chemotherapy","volume":"33","author":"Hardy","year":"1989","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0090-8258(92)90239-F","article-title":"Intracranial metastases from carcinoma cervix and review of literature","volume":"46","author":"Kumar","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2016.04.030_bb0055","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/1097-0142(19890901)64:5<1147::AID-CNCR2820640530>3.0.CO;2-1","article-title":"Neurologic complications of cervical cancer. A review of 2261 cases","volume":"64","author":"Saphner","year":"1989","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2016.04.030_bb0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/030089169608200420","article-title":"Brain metastases from cervical carcinoma","volume":"82","author":"Cormio","year":"1996","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.2001.6140","article-title":"Tumor distribution and survival in six patients with brain metastases from cervical carcinoma","volume":"81","author":"Mahmoud-Ahmed","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/1097-0142(197802)41:2<776::AID-CNCR2820410253>3.0.CO;2-E","article-title":"Central nervous system involvement by ovarian carcinoma: a complication of prolonged survival with metastatic disease","volume":"41","author":"Mayer","year":"1978","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2016.04.030_bb0075","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/1097-0142(19861101)58:9<2066::AID-CNCR2820580917>3.0.CO;2-Q","article-title":"Involvement of the central nervous system by ovarian carcinoma","volume":"58","author":"Stein","year":"1986","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2016.04.030_bb0080","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/1097-0142(19871115)60:10<2559::AID-CNCR2820601035>3.0.CO;2-7","article-title":"Central nervous system metastases in epithelial ovarian carcinoma","volume":"60","author":"Dauplat","year":"1987","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2004.05.026","article-title":"Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature","volume":"94","author":"Melichar","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1048-891x.2004.14326.x","article-title":"Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review","volume":"14","author":"Tangjitgamol","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/gyno.2002.6792","article-title":"Craniotomy for central nervous system metastases in epithelial ovarian carcinoma","volume":"87","author":"Pothuri","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0100","first-page":"613","article-title":"Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival","volume":"9","author":"Kinch","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.ygyno.2016.04.030_bb0105","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1158\/1078-0432.CCR-03-0589","article-title":"EphA2 expression is associated with aggressive features in ovarian carcinoma","volume":"10","author":"Thaker","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ygyno.2014.03.563","article-title":"Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma","volume":"133","author":"Matsuo","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.04.030_bb0115","series-title":"Practical Gynecologic Oncology","author":"Berek","year":"2010"},{"issue":"26","key":"10.1016\/j.ygyno.2016.04.030_bb0120","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ygyno.2016.04.030_bb0125","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.ygyno.2016.04.030_bb0130","first-page":"4932","article-title":"Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts","volume":"60","author":"Rofstad","year":"2000","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.2009.22.4279","article-title":"Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and\/or chemotherapy in patients with non-small-cell lung cancer","volume":"28","author":"Hanrahan","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2016.04.030_bb0140","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1158\/1078-0432.CCR-05-2338","article-title":"The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer","volume":"12","author":"Kamat","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.ygyno.2016.04.030_bb0145","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/cncr.24335","article-title":"EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer","volume":"115","author":"Kamat","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2016.04.030_bb0150","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/COC.0b013e3181ec5f4b","article-title":"Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer","volume":"34","author":"Matsuo","year":"2011","journal-title":"Am. J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2016.04.030_bb0155","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1158\/1078-0432.CCR-07-1017","article-title":"Clinical and biological significance of vascular endothelial growth factor in endometrial cancer","volume":"13","author":"Kamat","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jso.1149","article-title":"Ovarian cancer metastatic to the brain: what is the optimal management?","volume":"78","author":"McMeekin","year":"2001","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2007.11.027","article-title":"Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer","volume":"108","author":"Lee","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/gyno.2001.6384","article-title":"The effect of radiation therapy on brain metastases from endometrial carcinoma: a retrospective study","volume":"83","author":"Mahmoud-Ahmed","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2012.11.001","article-title":"Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial)","volume":"128","author":"Nasu","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijgo.2011.02.014","article-title":"Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994","volume":"114","author":"Cormio","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"10","key":"10.1016\/j.ygyno.2016.04.030_bb0185","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.1992.10.10.1553","article-title":"Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery","volume":"10","author":"Rodriguez","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2007.05.027","article-title":"Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: a retrospective analysis and literature review","volume":"107","author":"Chura","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1006\/gyno.2002.6653","article-title":"Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases","volume":"85","author":"Anupol","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2016.04.030_bb0200","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2016.04.030_bb0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.410330605","article-title":"Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?","volume":"33","author":"Vecht","year":"1993","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.04.030_bb0210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0360-3016(94)90558-4","article-title":"The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age","volume":"29","author":"Noordijk","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9422","key":"10.1016\/j.ygyno.2016.04.030_bb0215","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2016.04.030_bb0220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(99)00198-4","article-title":"Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases","volume":"45","author":"Kondziolka","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ygyno.2016.04.030_bb0225","doi-asserted-by":"crossref","first-page":"505","DOI":"10.6004\/jnccn.2008.0038","article-title":"Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy","volume":"6","author":"Ewend","year":"2008","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11060-009-0060-9","article-title":"The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Gaspar","year":"2010","journal-title":"J. Neuro-Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2016.04.030_bb0235","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2016.04.030_bb0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000658-197203000-00014","article-title":"Anti-angiogenesis: new concept for therapy of solid tumors","volume":"175","author":"Folkman","year":"1972","journal-title":"Ann. Surg."},{"issue":"6 Suppl. 16","key":"10.1016\/j.ygyno.2016.04.030_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sonc.2002.37264","article-title":"Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications","volume":"29","author":"Ferrara","year":"2002","journal-title":"Semin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2016.04.030_bb0250","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/bjc.2011.147","article-title":"Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases","volume":"104","author":"Jubb","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/1078-0432.CCR-09-2439","article-title":"Bevacizumab safety in patients with central nervous system metastases","volume":"16","author":"Besse","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2016.04.030_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2012.07.004","article-title":"An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases","volume":"78","author":"Sandler","year":"2012","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2016.04.030_bb0265","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2008.16.3055","article-title":"Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma","volume":"27","author":"Kreisl","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"10.1016\/j.ygyno.2016.04.030_bb0270","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1200\/JCO.2008.19.8721","article-title":"Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma","volume":"27","author":"Friedman","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.ygyno.2016.04.030_bb0275","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","article-title":"Treatment of brain metastases","volume":"33","author":"Lin","year":"2015","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816301639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816301639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T08:12:40Z","timestamp":1567843960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816301639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0090825816301639"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.030","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}